Vitafol-OB+DHA Dosage
Generic name: ASCORBIC ACID 70mg, VITAMIN D 10ug, .ALPHA.-TOCOPHEROL 13.5mg, THIAMINE MONONITRATE 1.6mg, RIBOFLAVIN 1.8mg, NIACIN 18mg, PYRIDOXINE HYDROCHLORIDE 2.5mg, FOLIC ACID 1700ug, CYANOCOBALAMIN 12ug, CALCIUM 100mg, IRON 65mg, MAGNESIUM 25mg, ZINC 25mg, COPPER 2mg, VITAMIN A 810ug; DOCONEXENT 250mg
Dosage form: caplets, capsules
Drug classes: Iron products, Vitamin and mineral combinations
Medically reviewed by Drugs.com. Last updated on Mar 20, 2025.
More about Vitafol-OB+DHA (multivitamin, prenatal)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Drug class: iron products
Patient resources
Other brands
Prenatal Multivitamins, Prenatal 19, Vitafol Ultra, Prenatabs FA, ... +25 more
Professional resources
Other brands
Prenatal 19, Vitafol Ultra, Prenatal Plus, Prenatabs FA, ... +34 more
Other formulations
Related treatment guides
See also:
FeroSul
FeroSul is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
Prenatal Multivitamins
Prenatal Multivitamins is used for vitamin/mineral supplementation during pregnancy/lactation
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Prenatal 19
Prenatal 19 is used for vitamin/mineral supplementation during pregnancy/lactation
Slow Fe
Slow Fe is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
Fergon
Fergon is used for anemia due to chronic kidney disease, iron deficiency anemia, vitamin/mineral ...
Feosol Original
Feosol Original is used for anemia due to chronic kidney disease, iron deficiency anemia ...
Vitafol Ultra
Vitafol Ultra is used for vitamin/mineral supplementation during pregnancy/lactation
Ferrous sulfate
Ferrous sulfate is used to treat iron deficiency anemia. Includes ferrous sulfate side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
